Matthew E. Layton
Impact in
-
- Sleep and Work-Related Fatigue
- Sleep and related disorders
- Pharmacology top 5%
- Coffee research and impacts
- Alkaloids: synthesis and pharmacology
Papers in
-
- Sleep and related disorders 9
- Sleep and Work-Related Fatigue 8
-
- Coffee research and impacts 3
- Co-authors
- Stephen R. Dager (7 shared papers)John Raymond White (7 shared papers)Hans P. A. Van Dongen (12 shared papers)John M. Roll (8 shared papers)Thomas L. Pazdernik (6 shared papers)Wayne L. Strauss (4 shared papers)Jennifer M. Cameron (1 shared paper)David M. Andrenyak (1 shared paper)
- Journals
- Chronobiology International (3 papers)American Journal of Psychiatry (3 papers)Neurochemical Research (2 papers)Clinical and Translational Science (2 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- United StatesAustraliaNetherlands
In The Last Decade
Matthew E. Layton
49 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 117
- Experimental and Cognitive Psychology 189
- Pharmacology 93
- Pharmacology 158
- Biological Psychiatry 20
- Physiology 198
Countries citing papers authored by Matthew E. Layton
This map shows the geographic impact of Matthew E. Layton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Layton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Layton more than expected).
Fields of papers citing papers by Matthew E. Layton
This network shows the impact of papers produced by Matthew E. Layton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Layton. The network helps show where Matthew E. Layton may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew E. Layton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 143 | |
| 2 | 2016 | 84 | |
| 3 | 2016 | 84 | |
| 4 | 1999 | 76 | |
| 5 | 1999 | 60 | |
| 6 | 2022 | 51 | |
| 7 | 1992 | 49 | |
| 8 | 1997 | 42 | |
| 9 | 1998 | 40 | |
| 10 | 2018 | 36 | |
| 11 | 2020 | 33 | |
| 12 | 2001 | 25 | |
| 13 | 2018 | 24 | |
| 14 | 2012 | 22 | |
| 15 | 1996 | 22 | |
| 16 | 2018 | 21 | |
| 17 | 2021 | 19 | |
| 18 | 2023 | 18 | |
| 19 | 1999 | 16 | |
| 20 | 2018 | 15 |
About Matthew E. Layton
Matthew E. Layton is a scholar working on Experimental and Cognitive Psychology, Pharmacology, Physiology, Cellular and Molecular Neuroscience and Cognitive Neuroscience, having authored 49 papers that have together received 1.1k indexed citations. Recurring topics across this work include Sleep and related disorders (9 papers), Sleep and Work-Related Fatigue (8 papers), Substance Abuse Treatment and Outcomes (4 papers), Ergonomics and Musculoskeletal Disorders (3 papers), Sleep and Wakefulness Research (3 papers), Smoking Behavior and Cessation (3 papers), Biochemical effects in animals (3 papers) and Coffee research and impacts (3 papers). The work is most often cited by research in Experimental and Cognitive Psychology (189 citations), Pharmacology (93 citations), Pharmacology (158 citations), Biological Psychiatry (20 citations) and Physiology (198 citations). Matthew E. Layton has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Stephen R. Dager, John Raymond White, Hans P. A. Van Dongen, John M. Roll, Thomas L. Pazdernik, Wayne L. Strauss, Jennifer M. Cameron, David M. Andrenyak, Donelle N. Howell and Seth D. Friedman. Their work appears in journals such as Chronobiology International, American Journal of Psychiatry, Neurochemical Research, Clinical and Translational Science and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.